Related Experiment Video
Updated: Aug 7, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma
H Niizuma1, Y Nakamura, T Ozaki
1Division of Biochemistry, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan.
Abstract:
Retinoic acid (RA) has been shown to induce neuronal differentiation and/or apoptosis, and is widely used as a chemotherapeutic agent for treating the patients with neuroblastoma. However, the therapeutic effect of RA is still limited. To unveil the molecular mechanism(s) inducing differentiation and apoptosis in neuroblastoma cells, we compared CHP134 and NB-39-nu cell lines, in which all-trans-RA (ATRA) induces apoptosis, with LA-N-5 and RTBM1 cell lines, in which it induces neuronal differentiation. Here, we found that Bcl-2 was strongly downregulated in CHP134 and NB-39-nu cells, whereas it was abundantly expressed in LA-N-5 and RTBM1 cells. ATRA-mediated apoptosis in CHP134 and NB-39-nu cells was associated with a significant activation of caspase-9 and caspase-3 as well as cytoplasmic release of cytochrome c from mitochondria in a p53-independent manner. Enforced expression of Bcl-2 significantly inhibited ATRA-mediated apoptosis in CHP134 cells. In addition, treatment of RTBM1 cells with a Bcl-2 inhibitor, HA14-1, enhanced apoptotic response induced by ATRA. Of note, two out of 10 sporadic neuroblastomas expressed bcl-2 at undetectable levels and underwent cell death in response to ATRA in primary cultures. Thus, our present results suggest that overexpression of Bcl-2 is one of the key mechanisms to give neuroblastoma cells the resistance against ATRA-mediated apoptosis. This may provide a new therapeutic strategy against the ATRA-resistant and aggressive neuroblastomas by combining treatment with ATRA and a Bcl-2 inhibitor.
Insights
Retinoic acid (RA) treats neuroblastoma but has limited effects. This study reveals that high Bcl-2 levels cause resistance to RA therapy by preventing apoptosis, suggesting combination treatments for aggressive neuroblastomas.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Retinoic acid (RA) is a chemotherapeutic agent for neuroblastoma, inducing neuronal differentiation or apoptosis.
- The therapeutic efficacy of RA is often limited, necessitating a deeper understanding of its molecular mechanisms in neuroblastoma.
- Investigating the differential responses of neuroblastoma cell lines to all-trans-RA (ATRA) is crucial for identifying resistance factors.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying ATRA-induced apoptosis versus neuronal differentiation in neuroblastoma.
- To identify key proteins or pathways that confer resistance to ATRA treatment in neuroblastoma cells.
- To explore novel therapeutic strategies for ATRA-resistant neuroblastoma.
Main Methods:
- Comparative analysis of neuroblastoma cell lines (CHP134, NB-39-nu, LA-N-5, RTBM1) treated with all-trans-RA (ATRA).
- Assessment of Bcl-2 expression levels, caspase activation (caspase-9, caspase-3), and cytochrome c release.
- Functional studies involving enforced Bcl-2 expression and Bcl-2 inhibitor (HA14-1) treatment.
Main Results:
- Bcl-2 was downregulated in ATRA-induced apoptosis cell lines (CHP134, NB-39-nu) and upregulated in ATRA-induced differentiation cell lines (LA-N-5, RTBM1).
- ATRA-induced apoptosis involved p53-independent caspase activation and cytochrome c release.
- Overexpression of Bcl-2 inhibited ATRA-induced apoptosis, while Bcl-2 inhibition enhanced ATRA's apoptotic effect.
Conclusions:
- Overexpression of Bcl-2 is a significant mechanism conferring resistance to ATRA-mediated apoptosis in neuroblastoma.
- Targeting Bcl-2 in combination with ATRA may offer a new therapeutic approach for aggressive and ATRA-resistant neuroblastomas.
- The findings highlight Bcl-2 as a potential biomarker for predicting ATRA response and a therapeutic target in neuroblastoma treatment.
More Related Videos
09:04Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cellular Injury V: Apoptosis and Autophagy